WELLS FARGO & COMPANY/MN - VIRAX BIOLABS GROUP LTD ownership

VIRAX BIOLABS GROUP LTD's ticker is and the CUSIP is G9495L109. A total of 5 filers reported holding VIRAX BIOLABS GROUP LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of VIRAX BIOLABS GROUP LTD
ValueSharesWeighting
Q3 2023$650
-16.7%
2,0000.0%0.00%
Q2 2023$7802,0000.00%
Other shareholders
VIRAX BIOLABS GROUP LTD shareholders Q3 2023
NameSharesValueWeighting ↓
UBS Group AG 147$480.00%
WELLS FARGO & COMPANY/MN 2,000$6500.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Citadel Advisors 16,362$5,3180.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 15,000$4,8750.00%
View complete list of VIRAX BIOLABS GROUP LTD shareholders